A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes

NCT02750410 · Completed

Last updated 2026-05-28

This clinical trial tested the medication dulaglutide in Japanese adults with type 2 diabetes to see how it affects their blood sugar levels over time.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, double-blind treatment study

Participants 159 people

Who can join Ages 20+ · all sexes

Timeline Started 2016-08 · est. completion 2018-06

Where 25 sites · Japan

What this study is testing ClinicalTrials.gov NCT02750410 ↗

Description as written by the study sponsor.

The main purpose of this study is to evaluate the efficacy and safety of combination therapy with dulaglutide and insulin in Japanese participants with type 2 diabetes.

Treatments tested

Dulaglutide also known as LY2189265 Drug

Administered subcutaneously (SC)
Placebo Drug

Administered SC

Main thing measured	Change From Baseline in Hemoglobin A1c (HbA1c)
Sponsor	Eli Lilly and Company
Conditions studied	Type 2 Diabetes
GLP-1 drugs	dulaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02750410 ↗